Back
icad Vs. Perspective Therapeutics Industry Stock Comparison
Buy
66
ICAD
icad
Last Price:
1.79
Seasonality Move:
15.33%
Sell
30
CATX
Perspective Therapeutics
Last Price:
8.92
Seasonality Move:
28.97%
Buy
66
icad (ICAD)
is a Buy
Is icad a Buy, Sell or Hold?
- The current icad [ICAD] share price is $2.34. The Score for ICAD is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- ICAD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $9.93. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ICAD Stock Price Chart
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $9.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
ICAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 71.23 | Buy |
| Chaikin Money Flow: | 25826 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.6 - 2.08) | Buy |
| Bollinger Bands (100): | (1.29 - 1.79) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 28.07 | Sell |
| Chaikin Money Flow: | -952055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.27 - 12.77) | Sell |
| Bollinger Bands (100): | (11.25 - 14.33) | Sell |
ICAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.03 | Buy |
| 20-day SMA: | 1.93 | Buy |
| 50-day SMA: | 1.69 | Buy |
| 200-day SMA: | 1.55 | Buy |
| 8-day EMA: | 2.11 | Buy |
| 20-day EMA: | 1.94 | Buy |
| 50-day EMA: | 1.76 | Buy |
| 200-day EMA: | 1.63 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.45 | Sell |
| 20-day SMA: | 11.83 | Sell |
| 50-day SMA: | 12.88 | Sell |
| 200-day SMA: | 12.8 | Sell |
| 8-day EMA: | 11.13 | Sell |
| 20-day EMA: | 11.74 | Sell |
| 50-day EMA: | 12.46 | Sell |
| 200-day EMA: | 11.73 | Sell |
icad Earnings Growth & ICAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.05 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and a decrease next year of $0.22 per share.
icad Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||